Rocket Pharmaceuticals (RCKT) Times Interest Earned (2016 - 2025)
Rocket Pharmaceuticals (RCKT) has disclosed Times Interest Earned for 9 consecutive years, with -$92.95 as the latest value for Q4 2025.
- Quarterly Times Interest Earned rose 29.88% to -$92.95 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$122.55 through Dec 2025, up 15.4% year-over-year, with the annual reading at -$122.55 for FY2025, 15.4% up from the prior year.
- Times Interest Earned hit -$92.95 in Q4 2025 for Rocket Pharmaceuticals, up from -$110.46 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$22.68 in Q1 2021 to a low of -$156.5 in Q2 2024.
- Historically, Times Interest Earned has averaged -$122.64 across 5 years, with a median of -$133.76 in 2023.
- Biggest five-year swings in Times Interest Earned: plummeted 928.35% in 2021 and later grew 29.88% in 2025.
- Year by year, Times Interest Earned stood at -$95.75 in 2021, then plummeted by 54.49% to -$147.93 in 2022, then increased by 8.98% to -$134.64 in 2023, then rose by 1.55% to -$132.55 in 2024, then increased by 29.88% to -$92.95 in 2025.
- Business Quant data shows Times Interest Earned for RCKT at -$92.95 in Q4 2025, -$110.46 in Q3 2025, and -$150.42 in Q2 2025.